Olaparib approved for 800 prostate and breast cancer patients in England

by

Olaparib (Lynparza), a targeted cancer drug, has been approved for hundreds of patients with certain breast cancers and prostate cancers in England.

Leave A Comment

Your email address will not be published. Required fields are marked *